Effectiveness of a novel immunogenic nanoparticle platform for Toxoplasma peptide vaccine in HLA transgenic mice

Interferon-γ: the Major Mediator of Resistance Against <i>Toxoplasma gondii</i>

Yasuhiro Suzuki, Manuel Orellana, Robert D. Schreiber et al. · Science · 1988 · 1.2K citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine

Ricardo T. Gazzinelli, Fran Hakim, Sara Hieny et al. · The Journal of Immunology · 1991 · 618 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides

Jeff Alexander, John Sidney, Scott Southwood et al. · Immunity · 1994 · 530 citations

Life Sciences, Immunology, Adaptive Immunity +11

Early and Longitudinal Evaluations of Treated Infants and Children and Untreated Historical Patients with Congenital Toxoplasmosis: The Chicago Collaborative Treatment Trial

James McAuley, K. M. Boyer, Dushyant V. Patel et al. · Clinical Infectious Diseases · 1994 · 401 citations

Medicine, Neurology, Pediatrics +8

The Crystal Structure of a Five-Stranded Coiled Coil in COMP: A Prototype Ion Channel?

V.N. Malashkevich, Richard A. Kammerer, Vladimir P. Efimov et al. · Science · 1996 · 303 citations

Life Sciences, Biochemistry, Biology +17